PA
ADI icon

PharVision Advisers’s Analog Devices ADI Stock Holding History

PharVision Advisers’s Portfolio ADI Stock Details ADI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-863
Closed -$212K – 674
2025
Q3 		$212K Sell
863
-862
-50% -$207K 0.12% 466
2025
Q2 		$411K Buy
1,725
+74
+4% +$15.4K 0.59% 23
2025
Q1 		$333K Buy
+1,651
New +$357K 0.46% 76

Other funds holding ADI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PharVision Advisers's ADI Position: Q4 2025 in Review

PharVision Advisers sold out of Analog Devices (ADI) in Q4 2025, closing a stake of 863 shares — an estimated $212K sold.

PharVision Advisers first reported a position in ADI in Q1 2025 and held it in 3 quarters. The position peaked at $411K in Q2 2025. 1,970 funds tracked by Wall St. Rank hold ADI as of Q4 2025.

  • PharVision Advisers reported no remaining Analog Devices position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 863 Analog Devices shares in Q4 2025, an estimated $212K.
  • PharVision Advisers first reported a position in Analog Devices in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Analog Devices position peaked at $411K in Q2 2025.
  • 1,970 funds tracked by Wall St. Rank held Analog Devices as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.